Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 5, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 17, 2016

Conditions
Thrombocytopenia
Interventions
BIOLOGICAL

CPP

One unit of frozen CPP contains approximately 3.4 x 10\^11 irradiated platelets and approximately 6% DMSO in sterile 0.9% sodium chloride solution (total volume of 20 mL to 35 mL) stored frozen at ≤ -65°C.

BIOLOGICAL

LSP

Trial Locations (4)

45267

Hoxworth Blood Center, Cincinnati

98104

Puget Sound Blood Center, Seattle

98195

University of Washington, Division of Hematology, Seattle

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

U.S. Army Medical Research and Development Command

FED

NCT02078284 - Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets | Biotech Hunter | Biotech Hunter